Skip to content

Study for the role of short-chain fatty acids in Helicobacter pylori-associated gastritis

Study for the role of short-chain fatty acids in Helicobacter pylori-associated gastritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028629
Enrollment
Unknown
Registered
2019-12-29
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The infection of Helicobacter pylori

Interventions

HP infection negative:Nil
HP infection positive group:Nil

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years old; 2. Did not take antibiotics and bismuth for 4 weeks before gastroscopy, and did not take drugs that affect Hp activity such as PPI and H2 receptor antagonists for 2 weeks; 3. No H. pylori eradication treatment in the past six months; 4. Exclude other serious cardiopulmonary diseases and history of previous malignant tumors; 5. The patient signs the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. gastroscopy with peptic ulcer, gastric cancer and other organic diseases of the digestive tract; 2. Receive Hp eradication treatment within the past six months; 3. history of other serious heart and lung diseases and previous malignant tumors; 4. The patient is unwilling to participate.

Design outcomes

Primary

MeasureTime frame
Short-chain fatty acids content;

Secondary

MeasureTime frame
Degree of chronic gastritis;

Countries

China

Contacts

Public ContactChangping Li

The Affiliated Hospital of Southwest Medical University

506854209@qq.com+86 13882731666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026